MRODS recognizes that Opiate Dependency is a medical disease and offers the most effective treatment against it. Rather than viewing addiction as a voluntary disorder, and blaming the addict, MRODS categorizes it with chronic physical illness caused by a combination of genetic, biological, behavioral, spiritual and social factors. The MRODS Opiate Addiction Treatment Program first confronts the opiate dependency as a treatable disease, and then addresses the underlying psychological issues as they surface.

The MRODS Opiate Dependence Treatment Program is a leader and sets a higher standard of quality in rapid opiate detoxification and addiction rehab from opiate dependency. MRODS has the staff and medical consultants backed by more than a decade of research and experience with thousands of AAROD procedures. This places MRODS's state of the art facilities, trained experts and tested protocols at the forefront of rapid detoxification. Many other rapid detoxifications have attempted rapid opiate detoxification on an outpatient basis and have experienced medical complications and documented mortality. MRODS uses only inpatient hospital settings in acute care medical facilities.

The MRODS Opiate Dependence Treatment Program recognizes the absolute necessity of addiction treatment beyond detoxification. To just detoxify a patient and send them on their way without appropriate continuing care just helps to continue the problem. MRODS Opiate Dependence Treatment Program.

The MRODS Opiate Dependence Treatment Program safely detoxifies patients while under anesthesia, and expels all opiates at the receptor level within 4 to 6 hours. MRODS has achieved a 100% success rate in detoxification at the receptor level with no immediate painful acute withdrawal symptoms while under anesthesia. Patients quitting before the withdrawal stage is finished undermine most detoxification treatments. Leaving MRODS's program before the body is completely cleared of active opiates is not an option for the AAROD patient while they are under anesthesia from beginning to end.

Published outcome studies and follow-up data has demonstrated the safety of AAROD and the increased positive outcomes. Demographic reports show that when thousands of MRODS patients have tried an average of four other conventional treatments, AAROD coupled with addiction treatment and Naltrexone injection implant worked where these others have repeatedly failed. Compared with an average 20% success rate of traditional opiate addiction programs, MRODS maintains unprecedented rates of success: approximately 60% of addicts treated remain clean after six months or longer.

MRODS offers the rapid transition from addiction to an opiate-free life and believe that the pain and psychological fear of prolonged detoxification can cause distress that may adversely affect further rehabilitation. This distress results in the high drop out rates, relapse cases and interruptions between traditional detoxification and the start of rehabilitation. The success of the MRODS AAROD Method is attributed to a smooth and rapid transition directly from detoxification into continuing care. With the addition of the relapse prevention medication (Naltrexone injection implant or oral tablets), this ensures maximum compliance with the recommended programs of education, counseling and opiate-antagonist medication (Naltrexone injection implant) without any lapse between detoxification and the start of their rehabilitative care.

The MRODS AAROD Method recognizes how legitimate pain issues can put an individual in the perils of opiate dependence. Many individuals being treated for legitimate chronic pain issues are at risk for becoming dependent on the very medications from which they seek relief for their pain through prescription opiates. MRODS recognizes that these pain issues are real and provides comprehensive treatment planning to assist the patient. MRODS uses experienced pain specialist's skills in helping these patients deal with their pain after AAROD to reduce the risk of re-addiction.

top ::